Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2-3
pubmed:dateCreated
1997-9-23
pubmed:abstractText
The urokinase receptor (u-PAR), a protein anchored to cell membrane by a glycosyl phosphatidylinositol, plays a central role in cancer cell invasion and metastasis by binding urokinase plasminogen activator (u-PA), thereby facilitating plasminogen activation. Plasmin can promote cell migration either directly or by activating metalloproteinases that degrade some of the components of the extra cellular matrix. However, the IGR-OV1-Adria cell line contains the u-PAR but does not migrate even in the presence of exogenous u-PA, although the parental IGR-OV1 cell line migrates normally in the presence of u-PA. We therefore investigated the role of cell signalling for u-PA induced cell locomotion. We show that cell migration induced by u-PA-u-PAR complex is always associated with tyrosine kinase activation for the following reasons: (1) the blockade of the u-PAR by a chimeric molecule (albumin-ATF) inhibits not only the u-PA-induced cell migration, but also the signalling in IGR-OV1 line; (2) the binding of u-PA to u-PAR on non-migrating IGR-OV1-Adria cells was not associated with tyrosine kinase activation; (3) the inhibition of tyrosine kinase also blocked cell migration of IGR-OV1. Therefore tyrosine kinase activation seems to be essential for the u-PA-induced cell locomotion possibly by the formation of a complex u-PAR-u-PA with a protein whose transmembrane domain can ensure cell signalling. Thus, IGR-OV1 and IGR-OV1-Adria cell lines represent a good model for the analysis of the mechanism of u-PA-u-PAR-induced cell locomotion.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jul
pubmed:issn
0014-5793
pubmed:author
pubmed:issnType
Print
pubmed:day
14
pubmed:volume
411
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
322-6
pubmed:dateRevised
2009-11-19
pubmed:meshHeading
pubmed-meshheading:9271229-Blotting, Western, pubmed-meshheading:9271229-Cell Movement, pubmed-meshheading:9271229-Enzyme-Linked Immunosorbent Assay, pubmed-meshheading:9271229-Female, pubmed-meshheading:9271229-Fibrinolysin, pubmed-meshheading:9271229-Glycosylphosphatidylinositols, pubmed-meshheading:9271229-Humans, pubmed-meshheading:9271229-Immunohistochemistry, pubmed-meshheading:9271229-Microscopy, Confocal, pubmed-meshheading:9271229-Ovarian Neoplasms, pubmed-meshheading:9271229-Phosphorylation, pubmed-meshheading:9271229-Phosphotyrosine, pubmed-meshheading:9271229-Plasminogen Activator Inhibitor 1, pubmed-meshheading:9271229-Receptors, Cell Surface, pubmed-meshheading:9271229-Receptors, Urokinase Plasminogen Activator, pubmed-meshheading:9271229-Signal Transduction, pubmed-meshheading:9271229-Tumor Cells, Cultured, pubmed-meshheading:9271229-Urokinase-Type Plasminogen Activator
pubmed:year
1997
pubmed:articleTitle
Defective cell migration in an ovarian cancer cell line is associated with impaired urokinase-induced tyrosine phosphorylation.
pubmed:affiliation
Laboratoire Sainte Marie, Hôtel Dieu, Parvis de Notre Dame, Paris, France.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't